Search clinical trials for: Immune Suppression

Total 58604 results

ANRS, Emerging Infectious Diseases
European and Developing Countries Clinical Trials Partnership (EDCTP); European...

Recruiting

Determination of Adequate Tuberculosis Regimen in Patients Hospitalized With HIV-associated Severe Immune Suppression (DATURA)

Tuberculosis | HIV-1-infection | Immuno-Deficiency

Uganda, Cambodia, Cameroon, Guinea, Vietnam, Zambia
Astellas Pharma Global Development, Inc.

Recruiting

Open-label, Multicenter Study of Intramuscular PRL-02 Depot in Patients With Advanced Prostate Cancer

Prostate Cancer | mCRPC | mCSPC

United States
University of Miami
National Institute on Minority Health and Health Disparities (NIMHD)

Recruiting

Integrated Navigation Services for Treatment Adherence, Counseling, and Research (INSTACARE)

HIV Infection Primary

United States
Asociacion para el Estudio de las Enfermedades...

Recruiting

Differences in Immune Response Among HIV-1-infected Individuals With Previous or Current COVID-19 (CoVIHDis). (CoVIHDis)

Covid19 | HIV-1-infection | Immune Suppression

Spain
Sichuan Cancer Hospital and Research Institute

Recruiting

TACE, Sorafenib and PD-1 Monoclonal Antibody in the Treatment of HCC

Liver Diseases | Digestive System Neoplasms | Liver Neoplasms | Hepatocellular Carcinoma | Antineoplastic Agents | Molecular Mechanisms of Pharmacological Action | Protein Kinase Inhibitors | Sorafenib

China
University of Colorado, Denver

Recruiting

Puberty Suppression and Cardiometabolic Health

Endothelial Dysfunction | Vascular Stiffness | Insulin Sensitivity/Resistance | Transgenderism

United States
Charles University, Czech Republic

Recruiting

Immune Homeostasis in Sepsis and Septic Shock (IMHOTEP)

Sepsis | Immune Deficiency | Immunologic Paralysis | Immunologic Suppression

Czechia
PENTA Foundation
Baylor College of Medicine; University Hospital Birmingham NHS Foundation Trust and other collaborators

Recruiting

DTG/3TC Fixed Dose Formulations for the Maintenance of Virological Suppression in Children With HIV Infection Aged 2 to <15 Years Old (D3 (Penta21))

HIV Infections

Spain, United Kingdom, Thailand, South Africa, Uganda
Institute of Human Virology, Nigeria
University of Maryland, Baltimore; University of Pittsburgh; University of Georgia and other collaborators

Recruiting

Caregiver Peer Support and ART Adherence Among Children (CaPS)

HIV | Adherence

Nigeria
State University of New York - Downstate Medical...

Recruiting

Assessment of Suppression of Cutaneous Allergic Responses and Pruritis by Topical Minocycline (GINA3)

Asthma | Allergic Rhinitis

United States
Hospital Israelita Albert Einstein

Recruiting

Post Transplant Cyclophosphamide in Matched Unrelated Donor Stem Cell Transplantation for Hematological Malignancies

Graft Versus Host Disease | Infection Viral | Bone Marrow Transplant Complications | Engraft Failure | Immunologic Suppression

Brazil
Shanghai Unicar-Therapy Bio-medicine Technology...
The First Affiliated Hospital of Soochow University

Recruiting

CD19 CAR-T Cells With CRS Suppression Technology for r/r CD19+ Acute Lymphoblastic Leukemia

Acute Lymphoblastic Leukemia | Relapse | CD19 Positive | Refractory

China
Fatih Demirkan, MD

Recruiting

Chronic Lymphocytic Leukemia Registry Study - Multicenter Prospective National Study (CLLTRegistry)

Chronic Lymphocytic Leukemia | Del(17P)

Turkey
AbbVie

Recruiting

A Study of Venetoclax in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Chronic Lymphocytic Leukemia (CLL) | Small Lymphocytic Lymphoma (SLL)

Australia, China, New Zealand, Taiwan
University of California, San Francisco
National Institute of Allergy and Infectious Diseases (NIAID)

Recruiting

SCOPE: Observational Study of the Consequences of the Protease Inhibitor Era (SCOPE)

HIV Infections

United States
University of Alabama at Birmingham

Active, not recruiting

Trem-1 and Ultraviolet Radiation-induced Immune Suppression

Skin Diseases

United States
Johns Hopkins University
National Institute on Minority Health and Health Disparities (NIMHD)

Completed

Technology Based Community Health Nursing to Improve Combination Anti-Retroviral Therapy (cART) Adherence and Virologic Suppression in Youth Living With HIV (Tech2Check)

HIV Infections | Adherence, Medication

United States
ViiV Healthcare
GlaxoSmithKline; Janssen Pharmaceuticals

Completed

A Phase IIb Study to Evaluate a Long-Acting Intramuscular Regimen for Maintenance of Virologic Suppression (Following Induction With an Oral Regimen of GSK1265744 and Abacavir/Lamivudine) in Human Immunodeficiency Virus Type 1 (HIV-1) Infected, Antiretroviral Therapy-Naive Adult Subjects

HIV Infections | Infection, Human Immunodeficiency Virus

Germany, Spain, France, United States, Canada
Johnson & Johnson Private Limited

Completed

A Study to Assess Safety of ImbruvicaTM in Indian Participants With Chronic Lymphocytic Leukemia or Mantle Cell Lymphoma Who Have Received at Least One Prior Therapy or Chronic Lymphocytic Leukemia With 17p Deletion

Lymphoma, Mantle-Cell | Leukemia, Lymphocytic, Chronic, B-Cell

India
Institut de Recherches Internationales Servier

Terminated

Study of AG-270 in Participants With Advanced Solid Tumors or Lymphoma With MTAP Loss

Lymphoma | Advanced Solid Tumors

United States, Spain, France
National Institute of Allergy and Infectious Diseases...
ViiV Healthcare

Completed

Long-Acting Cabotegravir Plus VRC-HIVMAB075-00-AB (VRC07-523LS) for Viral Suppression in Adults Living With HIV-1

HIV Infections

United States, Puerto Rico
ViiV Healthcare

Active, not recruiting

A Study to Evaluate Efficacy, Safety and Tolerability in Antiretroviral Therapy (ART)-Experienced Participants of at Least 50 Years of Age Living With Human Immunodeficiency Virus (HIV) With Virologic Suppression Who Switch to DTG/3TC FDC From BIC/FTC/TAF (EYEWITNESS)

HIV Infections | HIV

Netherlands, Germany, Mexico, Spain, United States, Belgium, Portugal, Canada, United Kingdom, Italy, Austria, France
Columbia University

Completed

Community Health Worker And MHealth to ImProve Viral Suppression (CHAMPS Pilot) (CHAMPS Pilot)

HIV/AIDS

United States
Acerta Pharma BV
National Institutes of Health (NIH)

Active, not recruiting

Acalabrutinib in Patients With Relapsed/Refractory and Treatment naïve Deletion 17p CLL/SLL

Chronic Lymphocytic Leukemia | Small Lymphocytic Lymphoma

United States
IrsiCaixa

Completed

Impact of Raltegravir Intensification on HIV-1-infected Subjects With Complete Viral Suppression Under Monotherapy With Protease Inhibitors

HIV-1 Infection

Spain
Asuman Kucukoner

Completed

Speech in Noise Discrimination Skills in Multiple Sclerosis Patients.

Multiple Sclerosis-Relapsing-Remitting

Turkey
Emory University
Bristol-Myers Squibb; Thrasher Research Fund; Sickle Cell Transplant Advocacy... and other collaborators

Active, not recruiting

Acute GVHD Suppression Using Costimulation Blockade to Expand Non-malignant Transplant (ASCENT)

Graft Versus Host Disease

United States
University of Alabama at Birmingham
University of Colorado, Denver; National Institute of Mental Health (NIMH); University... and other collaborators

Completed

Optimizing Viral Load Suppression in Kenyan Children on Antiretroviral Therapy (Opt4Kids)

Chronic HIV Infection

Kenya
Oslo University Hospital

Active, not recruiting

Immunosuppressive Drugs and Gut Microbiome: Pharmacokinetic- and Microbiome Diversity Effects (MicrobioTac)

Kidney Transplant; Complications | Immune Suppression

Norway
University of North Carolina, Chapel Hill
George Washington University; Instituto Dermatológico y Cirugía de Piel (IDCP)

Active, not recruiting

Promoting Viral Suppression Among Transgender Women Living With HIV in Santo Domingo

HIV

Dominican Republic
H. Lee Moffitt Cancer Center and Research Institute
National Heart, Lung, and Blood Institute (NHLBI); CTI BioPharma

Completed

A Phase I/II GVHD Prevention Trial Combining Pacritinib With Sirolimus-Based Immune Suppression

GVHD | Graft Vs Host Disease

United States
RAND
National Institute of Mental Health (NIMH); Mildmay Uganda Limited

Completed

Behavioral Economics Incentives to Support HIV Treatment Adherence in Sub-Saharan Africa

HIV/AIDS

Uganda
National Institute of Allergy and Infectious Diseases...
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National...

Completed

Quantitative Measurement and Correlates of the Latent HIV Reservoir in Virally Suppressed Ugandans

HIV

Uganda
ViiV Healthcare
GlaxoSmithKline; Janssen Pharmaceuticals

Active, not recruiting

Study to Evaluate the Efficacy, Safety, and Tolerability of Long-acting Intramuscular Cabotegravir and Rilpivirine for Maintenance of Virologic Suppression Following Switch From an Integrase Inhibitor in HIV-1 Infected Therapy Naive Participants

HIV Infections

United States, Germany, Netherlands, Spain, France, Canada, United Kingdom, Italy, South Africa, Russian Federation, Japan
City University of New York, School of Public Health
New York City Department of Health and Mental Hygiene

Completed

Program Refinements to Optimize Model Impact and Scalability Based on Evidence (PROMISE)

Hiv

United States
IRCCS San Raffaele
Bristol-Myers Squibb

Completed

Efficacy of Atazanavir/Ritonavir Monotherapy as Maintenance in Patients With Viral Suppression

HIV-1 Infection

Italy
AbbVie

Completed

A Study in Previously Untreated Chronic Lymphocytic Leukemia (CLL) Subjects, Excluding Those With the 17p Deletion, to Evaluate Debulking Regimens Prior to Initiating Venetoclax Combination Therapy

Chronic Lymphocytic Leukemia (CLL) | Small Lymphocytic Lymphoma (SLL)

United States
Boston University
National Institute of Mental Health (NIMH)

Active, not recruiting

Effectiveness of Transdiagnostic Cognitive Behavioral Therapy for Improving HIV Treatment Outcomes in South Africa (CETA)

HIV/AIDS | Violence

South Africa
Celgene

Completed

A Non-interventional Study of REVLIMID® (Lenalidomide) Treatment of IPSS Low- or Intermediate-1-risk Myelodysplastic Syndromes Associated With a Deletion 5q or Refractory/Relapsed Mantle Cell Lymphoma in Korea (RevlimidPMS)

Lymphoma, Follicular | Myelodysplastic Syndromes | Lymphoma, Mantle-Cell

Korea, Republic of
Appalachian State University
Standard Process

Completed

Beet Supplementation, Exercise, Inflammation

Inflammatory Response | Metabolic Disturbance | Immune Suppression

United States
University of Wisconsin, Madison
National Institute on Drug Abuse (NIDA)

Enrolling by invitation

Clinic-level Implementation of mHealth to Improve HIV Viral Suppression for Patients With Substance Use Disorders

HIV Infections | Substance Use Disorders

United States
National Heart, Lung, and Blood Institute (NHLBI)

Active, not recruiting

Ibrutinib, Fludarabine, and Pembrolizumab in High-Risk or Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Leukemia, Lymphocytic, Chronic, B-Cell | Chronic Lymphocytic Leukemia | Leukemia, Chronic Lymphatic | B-Cell Chronic Lymphocytic Leukemia | Leukemia, Lymphocytic, Chronic | B-Lymphocytic Leukemia, Chronic | Leukemia, Chronic Lymphocytic, B-Cell | Lymphocytic Leukemia, Chronic, B Cell | Lymphocytic Leukemia...

United States
University of California, San Francisco
University of Colorado, Denver; National Heart, Lung, and Blood Institute (NHLBI) and other collaborators

Active, not recruiting

Options for Delivering Isoniazid-Rifapentine (3HP) for TB Prevention (3HP Options Implementation Trial)

HIV/AIDS | Latent Tuberculosis | Tuberculosis

Uganda
Merck Sharp & Dohme LLC
Eisai Inc.

Active, not recruiting

Safety and Efficacy Study of Pemetrexed + Platinum Chemotherapy + Pembrolizumab (MK-3475) With or Without Lenvatinib (MK-7902/E7080) as First-line Intervention in Adults With Metastatic Nonsquamous Non-small Cell Lung Cancer (MK-7902-006/E7080-G000-315/LEAP-006)-China Extension Study

Nonsquamous Non-small Cell Lung Cancer

China
University of California, San Francisco

Completed

Adherence-Suppression-Resistance Relationships for Atripla Compared to Historical Antiretroviral Regimens

HIV Infections | Adherence
University of Kansas Medical Center
National Institute of Mental Health (NIMH); Children's Mercy Hospital Kansas... and other collaborators

Active, not recruiting

Evaluating HITSystem 2.1 to Improve Viral Suppression in Kenya

Pregnancy | HIV

Kenya
Eric Bernicker, MD

Terminated

Trial of Radiation and Gene Therapy Before Nivolumab for Metastatic Non-Small Cell Lung Carcinoma and Uveal Melanoma (ENSIGN)

Nonsquamous Nonsmall Cell Neoplasm of Lung | Metastatic Uveal Melanoma | Lung Squamous Cell Carcinoma Stage IV

United States
Johns Hopkins Bloomberg School of Public Health
University of California, San Francisco; University of Toronto; National Institute... and other collaborators

Completed

HIV Treatment Retention Interventions for Women Living With HIV (Siyaphambili Study)

HIV-1 Virologic Response

South Africa
Columbia University
National Institute of Nursing Research (NINR)

Active, not recruiting

Community Health Worker And MHealth to ImProve Viral Suppression (CHAMPS)

HIV/AIDS

United States
RAND
National Institute of Mental Health (NIMH); Arizona State University; Mildmay...

Active, not recruiting

INcentives and ReMINDers to Improve Long-term Medication Adherence (INMIND)

HIV/AIDS

Uganda

Search clinical trials for: Immune Suppression

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Romania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations